Cargando…

Current status and considerations on biosimilar in China

Detalles Bibliográficos
Autor principal: Wang, Junzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479963/
http://dx.doi.org/10.1186/1479-5876-10-S2-A38
_version_ 1782247486364057600
author Wang, Junzhi
author_facet Wang, Junzhi
author_sort Wang, Junzhi
collection PubMed
description
format Online
Article
Text
id pubmed-3479963
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-34799632012-10-26 Current status and considerations on biosimilar in China Wang, Junzhi J Transl Med Meeting Abstract BioMed Central 2012-10-17 /pmc/articles/PMC3479963/ http://dx.doi.org/10.1186/1479-5876-10-S2-A38 Text en Copyright ©2012 Wang; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Wang, Junzhi
Current status and considerations on biosimilar in China
title Current status and considerations on biosimilar in China
title_full Current status and considerations on biosimilar in China
title_fullStr Current status and considerations on biosimilar in China
title_full_unstemmed Current status and considerations on biosimilar in China
title_short Current status and considerations on biosimilar in China
title_sort current status and considerations on biosimilar in china
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479963/
http://dx.doi.org/10.1186/1479-5876-10-S2-A38
work_keys_str_mv AT wangjunzhi currentstatusandconsiderationsonbiosimilarinchina